$WRB — BUY 📊

$WRB — BUY 📊 W. R. Berkley Corporation, an insurance holding company, operates as a commercial line writer worldwide. 🎯 Q1 FY26 | Rev $4B | EPS $1.30 vs $1.14 🟢 💡 The market underestimated the earnings power of WRB's investment portfolio and underwriting margin improvements. While the beat is known, the full upward estimate revision cycle is not yet priced in, and the forward P/E remains low relative to historical averages given strong growth. 📉 Reward/Risk: 2.0:1 🏢 Business Quality: 8/10 - high-quality commercial insurer with consistent ROE, strong underwriting discipline, and diversified lines 📊 Valuation: fair to slightly cheap - trailing P/E 14.4x at historical median, forward P/E ~13x on revised estimates, P/B ~1.75x in line with peers, PEG ~0.6 on... 🔮 Catalyst: Consensus EPS estimate revisions following strong Q1 results 📊 Our read: BUY. Full analysis → https://stockduty.xyz/s/WRB0618 Also in play: $PWR $PRIM $MYRG $EME $APG

W. R. Berkley Corporation, an insurance holding company, operates as a commercial line writer worldwide.